ELAN
Elanco Animal Health
NYSE: ELAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.72
-4.37% today
Updated 2026-06-05
Market cap
$12.07B
P/E ratio
—
P/S ratio
2.47x
EPS (TTM)
$-0.50
Dividend yield
—
52W range
$13 – $28
Volume
5.9M
WallStSmart proprietary scores
44
out of 100
Grade: D
Sell
Investment rating
4.0
Growth
C5.5
Quality
C+3.5
Profitability
D3.0
Valuation
D5/9
Piotroski F-Score
Moderate
0.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$29.79
+37.15%
12-Month target
—
—
Intrinsic (DCF)
$19.48
Margin of safety
-31.98%
5 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 14.90% QoQ
Risks
- Altman Z 0.87 — distress zone
- Thin margins at -4.95%
- Negative free cash flow $-38.00M
- 31.98% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $4.41B | $4.42B | $4.44B | $4.71B | $4.89B |
| Net income | $-78.00M | $-1.23B | $338.00M | $-232.00M | $57.00M |
| EPS | — | — | — | — | $-0.50 |
| Free cash flow | $268.00M | $117.00M | $394.00M | $284.00M | $-38.00M |
| Profit margin | -1.77% | -27.87% | 7.61% | -4.92% | -4.95% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-29 | VANHIMBERGEN, ROBERT M | Buy | 8 | $23.85 |
| 2026-05-29 | SIMMONS, JEFFREY N | Buy | 119 | $23.85 |
| 2026-05-29 | MODI, RAJEEV A. | Buy | 62 | $23.85 |
Peer comparison
Smart narrative
Elanco Animal Health trades at $21.72. Our Smart Value Score of 44/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 0.87, it sits in the distress. TTM revenue stands at $4.89B. with profit margins at -4.95%. Our DCF model estimates intrinsic value at $19.48.
Frequently asked questions
What is Elanco Animal Health's stock price?
Elanco Animal Health (ELAN) trades at $21.72, on a P/S of 2.5x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Elanco Animal Health overvalued?
Elanco Animal Health carries a Smart Value Score of 44/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $19.48 against the $21.72 price, so on cash flow terms the market is paying a premium for Elanco Animal Health's growth. The Sell rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Elanco Animal Health (ELAN)?
The 12-month analyst consensus target is $29.79, about 37.2% above the current $21.72. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Elanco Animal Health (ELAN)?
Our DCF model estimates intrinsic value at $19.48, a -32.0% margin of safety versus today's $21.72. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Elanco Animal Health's revenue?
Elanco Animal Health's trailing twelve-month revenue is $4.89B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Elanco Animal Health's Altman Z-Score is 0.87, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio2.47x
ROE-3.72%
Beta1.70
50D MA$22.90
200D MA$22.50
Shares out0.50B
Float0.49B
Short ratio—
Avg volume5.9M
Performance
1 week+0.00%
1 month+18.98%
3 months+3.01%
YTD+4.42%
1 year—
3 years—
5 years—